Acutus Medical, Inc.
AFIB
$0.0302
-$0.0106-25.98%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 181.20% | 532.48% | 717.57% | 1,512.84% | 136.39% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 181.20% | 532.48% | 717.57% | 1,512.84% | 136.39% |
| Cost of Revenue | 86.70% | 242.59% | 294.66% | 10,528.83% | 107.53% |
| Gross Profit | 132.50% | -101.63% | -131.06% | -567.78% | -61.73% |
| SG&A Expenses | -28.86% | 259.83% | 2,807.16% | 30.12% | -27.79% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.14% | 182.68% | 250.65% | 324.55% | 0.11% |
| Operating Income | 55.59% | -142.73% | -194.98% | -206.80% | 16.19% |
| Income Before Tax | 63.39% | -107.13% | -111.56% | -115.77% | -143.03% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 63.58% | -107.22% | -111.68% | -115.88% | -143.27% |
| Earnings from Discontinued Operations | 92.77% | 2.23% | -65.07% | -371.27% | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 88.31% | -27.80% | -23.91% | -320.81% | -106.14% |
| EBIT | 55.59% | -142.73% | -194.98% | -206.80% | 16.19% |
| EBITDA | 56.10% | -148.14% | -210.72% | -153.98% | 16.04% |
| EPS Basic | 88.56% | -28.77% | -22.89% | -292.39% | -100.66% |
| Normalized Basic EPS | 36.36% | -152.97% | -211.74% | -172.20% | 29.34% |
| EPS Diluted | 88.56% | -83.20% | -61.53% | -799.06% | -161.10% |
| Normalized Diluted EPS | 36.36% | -143.02% | -177.06% | -3,620.00% | 7.77% |
| Average Basic Shares Outstanding | 2.24% | 2.58% | 2.92% | 2.96% | 2.72% |
| Average Diluted Shares Outstanding | 2.24% | -4.59% | -4.32% | -4.34% | -4.60% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |